Combination Treatment With Everolimus, Letrozole and Trastuzumab in Hormone Receptor and HER2/Neu-positive Patients With Advanced Metastatic Breast Cancer and Other Solid Tumors: Evaluating Synergy and Overcoming Resistance
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Everolimus (Primary) ; Letrozole (Primary) ; Trastuzumab (Primary)
- Indications Breast cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 25 Jan 2017 Planned End Date changed from 1 Jul 2018 to 1 Jul 2019.
- 25 Jan 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
- 12 Dec 2015 Results (n=10) presented at the 38th Annual San Antonio Breast Cancer Symposium